IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.1680
-0.0160 (-8.70%)
Nov 20, 2026, 4:00 PM EST - Market closed
IGC Pharma Employees
IGC Pharma had 70 employees as of March 31, 2025. The number of employees increased by 3 or 4.48% compared to the previous year. That makes IGC Pharma the 33,512th largest employer in the world and 4,374th in the United States.
Employees
70
Change (1Y)
3
Growth (1Y)
4.48%
Revenue / Employee
$15,800
Profits / Employee
-$92,086
Market Cap
19.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 70 | 3 | 4.48% | 70 | 0 |
| Mar 31, 2024 | 67 | 6 | 9.84% | 67 | 0 |
| Mar 31, 2023 | 61 | 9 | 17.31% | 61 | 0 |
| Mar 31, 2022 | 52 | 2 | 4.00% | 52 | 0 |
| Mar 31, 2021 | 50 | 0 | - | 50 | 0 |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 107 |
| Evaxion | 46 |
| Aardvark Therapeutics | 28 |
| LeonaBio | 19 |
| ABVC BioPharma | 19 |
| CervoMed | 15 |
| TransCode Therapeutics | 12 |
| Marker Therapeutics | 5 |
IGC News
- 2 days ago - IGC Pharma completes dosing in Phase 2 CALMA trial of IGC-AD1 - TheFly
- 11 days ago - IGC Pharma reports Q3 EPS (2c) vs. (2c) last year - TheFly
- 14 days ago - IGC Pharma Quarterly report: Q3 2026 - Filings
- 4 weeks ago - IGC Pharma Proxy statement: Proxy filing - Filings
- 4 weeks ago - IGC Pharma Proxy statement: Proxy filing - Filings
- 5 weeks ago - IGC Pharma announced the introduction of PRISM - TheFly
- 5 weeks ago - IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment - Accesswire
- 7 weeks ago - IGC Pharma completes enrollment in Phase 2 CALMA trial - TheFly